Back to Journals » Clinical Epidemiology » Volume 9

Maternal diabetes and incidence of childhood cancer – a nationwide cohort study and exploratory genetic analysis

Authors Deleskog A, den Hoed M, Tettamanti G, Carlsson S, Ljung R, Feychting M, Brooke HL

Received 25 July 2017

Accepted for publication 13 September 2017

Published 30 November 2017 Volume 2017:9 Pages 633—642

DOI https://doi.org/10.2147/CLEP.S147188

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Colin Mak

Peer reviewer comments 2

Editor who approved publication: Professor Henrik Toft Sorensen


Anna Deleskog,1,* Marcel den Hoed,2,3,* Giorgio Tettamanti,1 Sofia Carlsson,1 Rickard Ljung,1 Maria Feychting,1 Hannah L Brooke1

1Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, 2Department of Immunology, Genetics and Pathology, 3Science for Life Laboratory, Uppsala University, Uppsala, Sweden

*These authors contributed equally to this work

Background: The etiology of childhood cancer is not well understood, but may be linked to prenatal and perinatal factors, such as maternal diabetes. However, this association has not been examined in depth. We aimed to determine if maternal diabetes is associated with risk of childhood brain tumor (CBT), leukemia (all types combined and acute lymphoblastic leukemia [ALL] separately), and lymphoma.
Methods: All children born in Sweden between 1973 and 2014 (n=4,239,965) were followed from birth until first cancer diagnosis, age 15 years, or December 31, 2015. Data on maternal diabetes, childhood cancer, and covariates were obtained from nationwide health registers. ­Incidence rate ratios (IRRs) and 95% confidence intervals (CIs) were calculated using Cox ­regression adjusted for potential confounders/mediators. Additionally, we performed an exploratory analysis using results from published genome-wide association studies and functional annotation.
Results: Maternal diabetes was associated with lower risk of CBT (adjusted IRR [95% CI]: 0.56 [0.35–0.91]) and higher risk of leukemia (adjusted IRR: 1.47 [1.13–1.92] for all leukemia combined and 1.64 [1.23–2.18] for ALL). These associations were similar for both maternal type 1 diabetes and gestational diabetes. Associations of five previously identified genetic loci were compatible with a causal effect of diabetes traits on neuroblastoma and common Hodgkin’s lymphoma.
Conclusion: Children whose mother had diabetes had lower risk of CBT and higher risk of leukemia, compared with children whose mother did not have diabetes. Our results are compatible with a role of prenatal and perinatal glycemic environment in childhood cancer etiology.

Keywords: neoplasm, childhood, diabetes, fetal growth, perinatal environment
 

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]